Online citations, reference lists, and bibliographies.

Does The Hospitalization After A Cancer Diagnosis Modify Adherence To Process Indicators Of Diabetes Care Quality?

Laura Policardo, Alessandro Barchielli, Giuseppe Seghieri, Paolo Francesconi
Published 2016 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
AimsThis study was designed to answer the question whether surgery due to newly diagnosed cancer may modify quality of diabetes’ management, as suggested by current guidelines.MethodsAdherence to guideline composite indicator (GCI), a process indicator including one annual assessment of HbA1c and at least two among eye examination, serum lipids measurement and microalbuminuria, was evaluated between years 2011–2012 and 2014–2015 in 158,069 diabetic patients living in Tuscany, Italy, on 1 January 2011 and surviving on 31 December 2015, of whom 661 were hospitalized in index year 2013 for a surgery procedure due to a newly incident cancer. Difference in GCI modification (DELTA_GCI) of these patients was compared with that of diabetic people without cancer, strictly matched for main confounders by means of a propensity score.ResultsIn diabetic patients with cancer, GCI adherence increased by about 8 % between years 2011–2012 and 2014–2015. When compared with controls, DELTA_GCI increased by 6 % in cancer group compared with controls (p < 0.05), but any significance was lost after matching the groups by propensity score (3 %; p = NS).ConclusionsOur study suggests that a hospitalization for a surgical procedure due to a newly diagnosed cancer does not influence the compliance to a quality process indicator of diabetes care such as GCI.
This paper references
10.1001/archinte.166.17.1871
Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan.
Manami Inoue (2006)
10.1016/j.numecd.2014.01.009
Comparison of direct costs of type 2 diabetes care: different care models with different outcomes.
Carlo Bruno Giorda (2014)
10.1371/journal.pone.0091340
Systematic Age-Related Differences in Chronic Disease Management in a Population-Based Cohort Study: A New Paradigm of Primary Care Is Required
Alessandra Buja (2014)
10.1016/j.urolonc.2008.07.032
Does diabetes mellitus as a comorbid condition affect the health-related quality of life in prostate cancer survivors? Results of a population-based observational study
David F Penson (2008)
10.1038/sj.bjc.6602611
Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study
Anthony J Swerdlow (2005)
10.1001/jama.2008.824
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.
Bethany B. Barone (2008)
10.1016/0021-9681(87)90171-8
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
Mary E. Charlson (1987)
Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008 300(23):2754-64. PMID: 19088353
Pamela J. Goodwin (2009)
10.1007/s00520-014-2292-2
The individual and combined effect of colorectal cancer and diabetes on health-related quality of life and sexual functioning: results from the PROFILES registry
Pauline Aj Vissers (2014)
10.1007/s11764-015-0486-3
The impact of having both cancer and diabetes on patient-reported outcomes: a systematic review and directions for future research
Pauline Aj Vissers (2015)
10.1111/j.1464-5491.2006.01851.x
The impact of second-level specialized care on hospitalization in persons with diabetes: a multilevel population-based study.
Carlo Bruno Giorda (2006)
10.1007/s00592-016-0863-z
Impact of cancer diagnosis and treatment on glycaemic control among individuals with colorectal cancer using glucose-lowering drugs
Marjolein M. J. Zanders (2016)
10.2337/dc07-0544
Prospective Study of Hyperglycemia and Cancer Risk
Samantha L. Bowker (2007)
10.1111/j.1464-410X.2007.07184.x
Risk of new-onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen-deprivation therapy for prostate cancer.
Ithaar H. Derweesh (2007)
10.1111/j.1463-1318.2012.03097.x
Secondary diabetes associated with 5-fluorouracil-based chemotherapy regimens in non-diabetic patients with colorectal cancer: results from a single-centre cohort study.
J-P Feng (2013)
10.1159/000441567
Prevalence of Multiple Sclerosis in Tuscany (Central Italy): A Study Based on Validated Administrative Data
Daiana Bezzini (2015)
10.1016/s0084-3954(07)70271-3
Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women
James A. Stockman (2006)
10.1016/S0885-3924(96)00326-0
The management of diabetes in patients with advanced cancer.
Jeannie Poulson (1997)
10.1093/qjmed/hcu218
Management of diabetes in patients with cancer.
Peter Jacob (2015)
10.1007/s00592-015-0756-6
Association of diabetes and diabetes treatment with incidence of breast cancer
Esther García-Esquinas (2015)
10.1007/s00592-013-0504-8
Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials
Matteo Monami (2013)
Altered glucose metabolism during chemoradiation for head and neck cancer.
Nam P Nguyen (2009)
10.1016/s0084-4071(08)70151-9
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer
Adam S. Kibel (2007)
10.1093/eurpub/ckv159
Gender differences in the relationship between diabetes process of care indicators and cardiovascular outcomes.
Chiara Seghieri (2016)
mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen - deprivation therapy for prostate cancer
NP Nguyen (2007)
10.3322/caac.20078
Diabetes and cancer: a consensus report.
Edward L. Giovannucci (2010)
10.1111/j.1365-2354.2005.00564.x
Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelines.
Rachel McCoubrie (2005)
10.1007/s10072-015-2062-z
Reliability of administrative data for the identification of Parkinson’s disease cohorts
Filippo Baldacci (2015)
10.1007/s10549-007-9654-0
The impact of diabetes on survival following breast cancer
Lorraine L. Lipscombe (2007)
10.1007/s10620-009-0944-8
Colorectal Cancer Outcomes, Recurrence, and Complications in Persons With and Without Diabetes Mellitus: A Systematic Review and Meta-Analysis
Kelly B. Stein (2009)
10.1002/ijc.21600
Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada.
Marie-Claude Rousseau (2006)
Risk of new-onset diabetes Acta Diabetol (2016
IH Derweesh (2007)
10.1188/12.ONF.449-457
Diabetes and cancer: impact on health-related quality of life.
Denise Soltow Hershey (2012)
10.1371/journal.pone.0033839
The Impact of Adherence to Screening Guidelines and of Diabetes Clinics Referral on Morbidity and Mortality in Diabetes
Carlo Bruno Giorda (2012)
10.3121/cmr.2013.1156
Breast and Prostate Cancer Survivors in a Diabetic Cohort: Results from the Living With Diabetes Study
Adedayo A. Onitilo (2013)
10.1186/1477-7525-4-17
A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer
Samantha L. Bowker (2006)
Regional Board for Diabetes Care of Piemonte (2006) The impact of second-level specialized care on hospitalization in persons with diabetes: a multilevel population-based study
C Giorda (2006)
10.2337/dc09-0647
Determinants of Quality in Diabetes Care Process
Roberto Gnavi (2009)
10.1007/s00592-016-0839-z
Diabetology and oncology meet in a network model: union is strength
Marco Gallo (2016)
10.1186/1471-2458-13-15
Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey
Rosa Gini (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar